Tudor Investment Corp’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-24,464
Closed -$58.7K 1574
2023
Q4
$58.7K Buy
24,464
+2,081
+9% +$4.99K ﹤0.01% 1390
2023
Q3
$76.1K Buy
+22,383
New +$76.1K ﹤0.01% 1401
2022
Q2
Sell
-32,557
Closed -$1.34M 1665
2022
Q1
$1.34M Buy
+32,557
New +$1.34M 0.03% 707
2021
Q4
Sell
-35,580
Closed -$1.78M 1733
2021
Q3
$1.78M Buy
35,580
+30,787
+642% +$1.54M 0.03% 635
2021
Q2
$302K Sell
4,793
-4,100
-46% -$258K 0.01% 1263
2021
Q1
$826K Sell
8,893
-7,756
-47% -$720K 0.02% 918
2020
Q4
$1.49M Buy
+16,649
New +$1.49M 0.04% 533
2017
Q2
Sell
-7,000
Closed -$203K 1093
2017
Q1
$203K Sell
7,000
-2,700
-28% -$78.3K 0.01% 1211
2016
Q4
$319K Buy
+9,700
New +$319K 0.01% 967
2016
Q3
Sell
-16,200
Closed -$456K 1444
2016
Q2
$456K Sell
16,200
-8,432
-34% -$237K 0.01% 756
2016
Q1
$895K Sell
24,632
-2,164
-8% -$78.6K 0.02% 426
2015
Q4
$1.07M Sell
26,796
-5,570
-17% -$223K 0.03% 324
2015
Q3
$922K Buy
32,366
+17,066
+112% +$486K 0.03% 371
2015
Q2
$504K Buy
15,300
+2,608
+21% +$85.9K 0.01% 738
2015
Q1
$365K Buy
12,692
+5,192
+69% +$149K 0.01% 914
2014
Q4
$204K Sell
7,500
-16,500
-69% -$449K 0.01% 1250
2014
Q3
$511K Sell
24,000
-5,400
-18% -$115K 0.02% 644
2014
Q2
$660K Buy
29,400
+8,657
+42% +$194K 0.03% 377
2014
Q1
$524K Buy
+20,743
New +$524K 0.02% 481
2013
Q3
Sell
-21,900
Closed -$316K 830
2013
Q2
$316K Buy
+21,900
New +$316K 0.02% 521